Below a list of forthcoming submissions that have recently been added to the SMC's work programme.

• Aclidinium bromide with formoterol fumarate dihydrate (Duaklir Genuair)
• Etanercept (Enbrel)
• Idelalisib (Zydelig)
• Ledipasvir with sofosbuvir (Harvoni)
• Levonorgestrel intrauterine delivery system (Jaydess)
• Ponatinib (Iclusig)
• Regorafenib monohydrate (Stivarga)
• Sucroferric oxyhydroxide (Velphoro)
• Tacrolimus (Envarsus)

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions